These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 20427872

  • 1. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP, Soni SS, Adikey GK, Raman A.
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [Abstract] [Full Text] [Related]

  • 2. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 May; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 3. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 4. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A, Rocca B, Salvatori G, Ciancia M, De Cristofaro R, Antonelli M.
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [Abstract] [Full Text] [Related]

  • 5. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 6. Effects of dermatan sulfate for anticoagulation in continuous renal replacement therapy.
    Vitale C, Verdecchia C, Bagnis C, Ganzaroli M, Giorcelli G, Marangella M.
    J Nephrol; 2008 Jun; 21(2):205-12. PubMed ID: 18446715
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA, Spiss CK, Gamsjäger T, Domenig C, Zimpfer M.
    Wien Klin Wochenschr; 2002 Feb 15; 114(3):96-101. PubMed ID: 12060975
    [Abstract] [Full Text] [Related]

  • 8. Anticoagulation for continuous renal replacement therapy.
    Tolwani AJ, Wille KM.
    Semin Dial; 2009 Feb 15; 22(2):141-5. PubMed ID: 19426417
    [Abstract] [Full Text] [Related]

  • 9. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
    Holt AW, Bierer P, Glover P, Plummer JL, Bersten AD.
    Intensive Care Med; 2002 Nov 15; 28(11):1649-55. PubMed ID: 12415456
    [Abstract] [Full Text] [Related]

  • 10. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.
    Birnbaum J, Spies CD, Klotz E, Hein OV, Morgera S, Schink T, Ziemer S, Grund MS, Saalmann R, Kox WJ, Lehmann C.
    Ren Fail; 2007 Nov 15; 29(3):271-7. PubMed ID: 17497439
    [Abstract] [Full Text] [Related]

  • 11. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge.
    Gabutti L, Marone C, Colucci G, Duchini F, Schönholzer C.
    Intensive Care Med; 2002 Oct 15; 28(10):1419-25. PubMed ID: 12373466
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep 15; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 15. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
    du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P.
    Crit Care; 2006 Sep 15; 10(2):R45. PubMed ID: 16542495
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.
    Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, Butt W, Scheinkestel C.
    Crit Care Resusc; 2014 Jun 15; 16(2):131-7. PubMed ID: 24888284
    [Abstract] [Full Text] [Related]

  • 19. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.
    Garcés EO, Victorino JA, Thomé FS, Röhsig LM, Dornelles E, Louzada M, Stifft J, de Holanda F, Veronese FV.
    Ren Fail; 2010 Jan 15; 32(3):320-7. PubMed ID: 20370447
    [Abstract] [Full Text] [Related]

  • 20. Continuous veno-venous hemodiafiltration in children after cardiac surgery.
    Jander A, Tkaczyk M, Pagowska-Klimek I, Pietrzykowski W, Moll J, Krajewski W, Nowicki M.
    Eur J Cardiothorac Surg; 2007 Jun 15; 31(6):1022-8. PubMed ID: 17403606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.